Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cordes

Showing results (161-170 of 178) with videos related to

Pageof 18
Sort By:
Nature|October 14, 2021
A bimodal burst energy distribution of a repeating fast radio burst sourceD Li, P Wang, W W Zhu, et al.
Nature|December 16, 2021
Author Correction: A bimodal burst energy distribution of a repeating fast radio burst sourceD Li, P Wang, W W Zhu, et al.
Journal for Immunotherapy of Cancer|March 25, 2026
Phase II study of olaparib and durvalumab in patients with metastatic castration-resistant prostate cancerChennan Li, Ravi A Madan, Min-Jung Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2020
Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary CancerHeather J Chalfin, Tiziano Pramparo, Amir Mortazavi, et al.
Science (New York, N.Y.)|May 17, 2008
An eccentric binary millisecond pulsar in the galactic planeDavid J Champion, Scott M Ransom, Patrick Lazarus, et al.
Nature|November 1, 2022
Publisher Correction: A repeating fast radio burst associated with a persistent radio sourceC-H Niu, K Aggarwal, D Li, et al.
The Lancet. Oncology|July 10, 2020
Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trialAndrea B Apolo, Rosa Nadal, Yusuke Tomita, et al.
Nature|June 8, 2022
A repeating fast radio burst associated with a persistent radio sourceC-H Niu, K Aggarwal, D Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2020
Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary TumorsAndrea B Apolo, Rosa Nadal, Daniel M Girardi, et al.
Nature|January 12, 2018
An extreme magneto-ionic environment associated with the fast radio burst source FRB 121102D Michilli, A Seymour, J W T Hessels, et al.
Pageof 18

Showing results (161-170 of 178) with videos related to

Sort By:
Pageof 18
Nature|October 14, 2021
A bimodal burst energy distribution of a repeating fast radio burst sourceD Li, P Wang, W W Zhu, et al.
Nature|December 16, 2021
Author Correction: A bimodal burst energy distribution of a repeating fast radio burst sourceD Li, P Wang, W W Zhu, et al.
Journal for Immunotherapy of Cancer|March 25, 2026
Phase II study of olaparib and durvalumab in patients with metastatic castration-resistant prostate cancerChennan Li, Ravi A Madan, Min-Jung Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2020
Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary CancerHeather J Chalfin, Tiziano Pramparo, Amir Mortazavi, et al.
Science (New York, N.Y.)|May 17, 2008
An eccentric binary millisecond pulsar in the galactic planeDavid J Champion, Scott M Ransom, Patrick Lazarus, et al.
Nature|November 1, 2022
Publisher Correction: A repeating fast radio burst associated with a persistent radio sourceC-H Niu, K Aggarwal, D Li, et al.
The Lancet. Oncology|July 10, 2020
Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trialAndrea B Apolo, Rosa Nadal, Yusuke Tomita, et al.
Nature|June 8, 2022
A repeating fast radio burst associated with a persistent radio sourceC-H Niu, K Aggarwal, D Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2020
Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary TumorsAndrea B Apolo, Rosa Nadal, Daniel M Girardi, et al.
Nature|January 12, 2018
An extreme magneto-ionic environment associated with the fast radio burst source FRB 121102D Michilli, A Seymour, J W T Hessels, et al.
Pageof 18